INMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 175.5% based on the discounted cash flow analysis.
| Market cap | $814.84 Million |
|---|---|
| Enterprise Value | $441.74 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.45 |
| Beta | 1.93 |
| Outstanding Shares | 63,401,000 |
| P/E Ratio | 9.74 |
|---|---|
| PEG | -26.71 |
| Price to Sales | 2.67 |
| Price to Book Ratio | 1.34 |
| Enterprise Value to Revenue | 1.18 |
| Enterprise Value to EBIT | 4.51 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.0569▲ 71.88% |
|---|---|
| Total Calls | 367,500▼ 57.83% |
| Total Puts | 755,900▼ 35.18% |
Holdings and activity of institutional investors.
| Ownership % | 51.87%▼ 0.94% |
|---|---|
| Total Invested | $458.47M▼ 8.59% |
| Investors Holding | 202▼ 4.00% |
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...